Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum
about
Plasmodium malaria and antimalarial antibodies in the first year of lifeBehaviour and molecular identification of Anopheles malaria vectors in Jayapura district, Papua province, IndonesiaTargeting vivax malaria in the Asia Pacific: The Asia Pacific Malaria Elimination Network Vivax Working GroupComa associated with microscopy-diagnosed Plasmodium vivax: a prospective study in Papua, IndonesiaHigh morbidity during treatment and residual pulmonary disability in pulmonary tuberculosis: under-recognised phenomenaMajor burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance studyA new Plasmodium vivax reference sequence with improved assembly of the subtelomeres reveals an abundance of pir genesMalaria Distribution, Prevalence, Drug Resistance and Control in IndonesiaA novel multiple-stage antimalarial agent that inhibits protein synthesisAnalysis of ex vivo drug response data of Plasmodium clinical isolates: the pros and cons of different computer programs and online platforms.Vivax malaria: a major cause of morbidity in early infancy.In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.Severe malarial thrombocytopenia: a risk factor for mortality in Papua, IndonesiaParasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria.Relationship of cell-free hemoglobin to impaired endothelial nitric oxide bioavailability and perfusion in severe falciparum malariaIncreased asymmetric dimethylarginine in severe falciparum malaria: association with impaired nitric oxide bioavailability and fatal outcomeAge-related susceptibility to severe malaria associated with galectin-2 in highland PapuansGeographical variation in Plasmodium vivax relapseIn vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.The incidence of malaria in travellers to South-East Asia: is local malaria transmission a useful risk indicator?In vivo and in vitro efficacy of chloroquine against Plasmodium malariae and P. ovale in Papua, Indonesia.A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance.Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P. vivaxCost-effectiveness of pre-referral antimalarial, antibacterial, and combined rectal formulations for severe febrile illnessDifferential cellular recognition of antigens during acute Plasmodium falciparum and Plasmodium vivax malaria.Quantitative Proteomics Analysis of Plasmodium vivax Induced Alterations in Human Serum during the Acute and Convalescent Phases of Infection.The burden and treatment of HIV in tuberculosis patients in Papua Province, Indonesia: a prospective observational studyHighly effective therapy for maternal malaria associated with a lower risk of vertical transmission.Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivaxAugmented plasma microparticles during acute Plasmodium vivax infectionImpaired skeletal muscle microvascular function and increased skeletal muscle oxygen consumption in severe falciparum malaria.Rosetting in Plasmodium vivax: a cytoadhesion phenotype associated with anaemiaMortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia.Gametocyte dynamics and the role of drugs in reducing the transmission potential of Plasmodium vivaxA simulation model of the within-host dynamics of Plasmodium vivax infection.Comparison of rapid diagnostic test Plasmotec Malaria-3, microscopy, and quantitative real-time PCR for diagnoses of Plasmodium falciparum and Plasmodium vivax infections in Mimika Regency, Papua, IndonesiaImpaired systemic tetrahydrobiopterin bioavailability and increased dihydrobiopterin in adult falciparum malaria: association with disease severity, impaired microvascular function and increased endothelial activation.Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax.Modeling the effects of relapse in the transmission dynamics of malaria parasites.Preserved dendritic cell HLA-DR expression and reduced regulatory T cell activation in asymptomatic Plasmodium falciparum and P. vivax infection.
P2860
Q26315542-F2B12723-356F-443A-8E51-9BC0711767C7Q26315566-49B177E2-B9ED-4E85-AD1F-E1E56185E85EQ27304660-13CF534F-693E-4654-B526-14A6D66C0CC9Q27306352-A8A35F08-A064-4AD3-93B9-ADE3C2D3D769Q28391941-373ACA9C-2C49-430C-B109-A2997E41B762Q28537653-48B5085C-F255-4194-B1AB-2AE8CA70B92CQ28585693-6FAFA530-6083-40C6-AF1C-E5ED7B52FF6BQ29306432-3B0671D2-018F-4698-ABFD-98EB753680E0Q30044020-5D8B553F-D753-44A5-B67C-A379F64C57B3Q30489045-E6C81C04-819D-48DB-8BFF-B9C5BECD9099Q33384482-24C27909-1B1A-4A91-BC13-67C33B1FC9C0Q33395221-299AF546-1EF4-445F-8568-1D06B93C8A60Q33417393-A15962B5-7F1C-4C99-A368-82A0389DA2CDQ33434467-86DCAFB1-7129-4D8E-A5EE-DE7AB9069C69Q33508667-FA95B3C4-82B5-430A-8B63-8F5D4621E2CFQ33565412-FF1E3C64-CF9E-48DD-B344-58CC1E042EB7Q33586454-038F360B-3ED3-431D-BD78-FF245C739E7EQ33613545-9A6EB89C-0EE2-4B60-A457-F3C98714AB70Q33704762-9789D1CF-4BB7-463E-9A32-99801B2096C4Q33710180-E69C3887-2B8E-4421-A6C0-719000266726Q33715256-DE7DABD7-BA1C-45D6-AEFD-BBB65B2610C1Q33761137-30E4FF30-9AF6-4F2B-BED0-5FB388F53C6DQ33764147-66572846-4A7F-4A4A-9EDB-0F395A878C33Q33785764-0D122C43-0D14-42B8-A6DB-8F495D0ED949Q33857969-2846C7AC-6216-43C9-BA5A-8C5F52C15F55Q33860793-07B592AE-680D-44C0-B4C7-B2EC5F4212D6Q33909586-F07810BC-8DA9-49F5-9160-5D5094077051Q34016031-D4AB8697-E199-4185-A0F4-D57E0759D000Q34360576-6EA27F49-42FF-4A1B-8914-543421CD5822Q34388168-7AAB559A-36ED-460B-A31C-2D61E1ADD483Q34480782-0DCB918A-C0A5-41FE-A7DB-AF750F3165EEQ34675111-AD2A8FA0-8640-439C-92B8-AC9B5FE3867BQ34686612-23ACCE2F-FDA8-4C4F-833A-8B7D3D1DD5B8Q34772862-210E8411-BE6F-4948-92D4-A9C4601D49C6Q35068421-E8FC8109-4B3A-4B47-A132-11D380A600C3Q35166939-46C6CE86-B08C-4A2D-B6AA-BF9A1AD43770Q35170674-1C2A911F-C58D-43D4-9F92-E8DE60069DF5Q35191550-904FE130-F33E-4F16-8022-4F4198F75E16Q35237540-C5775F0B-E762-440F-AE9F-D594E67BE4ACQ35649424-3C0C1507-CCC7-45FF-A81E-4458D683F264
P2860
Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Malaria morbidity in Papua Ind ...... ivax and Plasmodium falciparum
@ast
Malaria morbidity in Papua Ind ...... ivax and Plasmodium falciparum
@en
type
label
Malaria morbidity in Papua Ind ...... ivax and Plasmodium falciparum
@ast
Malaria morbidity in Papua Ind ...... ivax and Plasmodium falciparum
@en
prefLabel
Malaria morbidity in Papua Ind ...... ivax and Plasmodium falciparum
@ast
Malaria morbidity in Papua Ind ...... ivax and Plasmodium falciparum
@en
P2093
P2860
P50
P921
P356
P1433
P1476
Malaria morbidity in Papua Ind ...... ivax and Plasmodium falciparum
@en
P2093
Ketut Gde Umana
Lenny Burdarm
Maurits J Okoseray
Noah Wariker
Paulus Sugiarto
Peter Ebsworth
Ram Vemuri
Rilia Maristela
Shunmay Yeung
P2860
P2888
P356
10.1186/1475-2875-7-148
P577
2008-08-02T00:00:00Z
P5875
P6179
1034926835